Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively

25 Mar 2022

Abstract excerpt

Background: Protein disulfide isomerase A3 (PDIA3) is a member of the protein disulfide isomerase (PDI) family that participates in protein folding through its protein disulfide isomerase function. It has been reported to regulate the progression of several cancers, but its function in cancer immunotherapy is unknown. Methods: The RNA-seq data of cancer and normal tissues were downloaded from The Cancer Genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endoplasmic Reticulum Stress and Disease
Share to Ferroptosis and cancer prognosis
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35401558
DOI: 10.3389/fimmu.2022.837512

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response EffectivelyPMID 35401558Read ↗

PDIA3 correlates with clinical malignant features and immune signature in human gliomas.Semantic proximity Read ↗

PDIA6 promotes immune escape of head and neck squamous cell carcinoma by regulating TIGIT/CD155 axisSemantic proximity Read ↗

P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.Semantic proximity Read ↗

Emerging roles of protein disulfide isomerase in cancerSemantic proximity Read ↗

Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.Semantic proximity Read ↗

A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progressionSemantic proximity Read ↗

PDIA6 acts as a prognostic biomarker and immune regulator in HNSCC with novel insights into EBV associated nasopharyngeal carcinomaSemantic proximity Read ↗

Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathwaySemantic proximity Read ↗

FNDC3B is a Potential Prognostic Biomarker and Correlated With Immune Infiltrates in GliomaSemantic proximity Read ↗

PDIA6 promotes glioma malignancy by activating the IRE1α- p-HSP27 signaling axisSemantic proximity Read ↗

MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer typesSemantic proximity Read ↗

Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer typesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.